In mid-2010, Bayer introduced a new, permanent contraceptive implant called Essure to the Australian pharmaceutical market. Eight years later, upon hearing reports that hundreds of women across Australia had suffered complications from the device, Slater and Gordon announced it would pursue a class action against Bayer.

On this episode of The Lawyers Weekly Show, Jerome Doraisamy is joined by Slater and Gordon associate Ebony Birchall to discuss this class action and reveal the outcome that claimants are hoping for.

www.lawyersweekly.com.au